Sun Pharma Fertigyn 5000IU

Human Chorionic Gonadotropin (HCG) is a potent polypeptide hormone found in pregnant women. It is commonly utilized in medical treatments for conditions including cryptorchidism, female infertility, hypogonadism (low testosterone), and weight loss.

HCG is also frequently used by many anabolic steroid users in conjunction with steroid use or during the recovery period after discontinuation. When steroids are in use, the aim of HCG supplementation is to address hormonal suppression caused by steroid use. Post-steroid use, HCG is deployed to facilitate recovery and restore hormonal balance.

One prominent contemporary use of HCG is as a dietary aid. The HCG diet has gained considerable traction in Western medicine, although its effectiveness is widely debated. Both the American Medical Association and the American Society of Bariatric Physicians have criticized the HCG diet, asserting that weight loss can be attributed mainly to the extreme caloric restriction often implemented alongside it, which typically includes only 500 calories per day. Furthermore, research indicates that HCG does not stimulate the thyroid, act as a beta-2 stimulant, suppress appetite, or possess any characteristics related to thermogenic or fat-burning agents. Despite many physicians reporting success with the HCG diet, the severe caloric restriction raises concerns regarding its viability as a healthy long-term solution. Currently, there is insufficient evidence proving that the weight loss attributed to the HCG diet would occur independently of the severe dietary restrictions involved. The controversy surrounding this diet is expected to persist for many years.

The impact of HCG on anabolic steroid users can be categorized into two primary areas: post-cycle therapy (PCT) and usage during an active cycle. Anabolic steroid use generally suppresses natural testosterone production, with the extent of suppression depending on the types and doses of steroids employed. Following the cessation of steroid use, natural testosterone production will eventually resume, but this process can be slow and is often accompanied by very low testosterone levels and related symptoms, which can hinder muscle retention due to cortisol dominance. To mitigate these issues, many steroid users implement a PCT regimen to facilitate recovery. This approach accelerates recovery, although it may not restore hormone levels to their normal range without additional support. During this recovery phase, users require adequate testosterone levels to maintain proper body function as natural levels gradually increase.

Numerous PCT protocols exist, with most containing Selective Estrogen Receptor Modulators (SERMs) such as Nolvadex (Tamoxifen Citrate) and/or Clomid (Clomiphene Citrate). Some individuals have found that initiating a PCT plan with HCG prior to SERM administration enhances overall recovery. In essence, HCG mimics luteinizing hormone (LH) and prepares the body for the upcoming SERM treatment, leading to a more effective recovery process.

The second positive effect of HCG for steroid users involves its use during an active steroid cycle. Steroid use often leads to testicular atrophy due to suppressed natural testosterone production. By supplementing with HCG during this period, users can maintain testicular size. While this offers no significant strategic advantage, it may provide some benefit by keeping the body primed with exogenous LH, potentially easing recovery when steroid usage stops. However, caution is necessary, as the body can become reliant on HCG for its LH needs. Unlike anabolic steroids, which do not induce dependence, HCG can lead to dependency if not managed properly. For users who are not suffering from low testosterone, careful regulation and monitoring of HCG use during cycles are essential to prevent dependence, as excessive use can cause more harm compared to many anabolic steroids. Appropriately managed, on-cycle HCG use can aid in facilitating a smoother recovery, but responsible usage is crucial. Whether used during cycles or as part of PCT, HCG administration must be carefully regulated.

For anabolic steroid users, particularly those using HCG during cycles, a typical dose is 250 IU every 4-5 days, which is generally deemed sufficient to achieve the desired results without jeopardizing future natural testosterone production.

The final dosing protocol pertains to PCT use, with two effective methods. The first approach recommends administering 1,500-4,000 IU every 3-4 days for 2-3 weeks, followed by the initiation of SERM therapy. Alternatively, a potentially more effective method involves daily doses of 500-1,000 IU for ten consecutive days, followed by SERM therapy afterward.

Timing is crucial when using HCG during PCT. If your steroid cycle concludes with long-estered steroids, HCG therapy should commence ten days post-injection and be followed by SERM therapy. Conversely, if the cycle ends with short-estered steroids, HCG therapy should begin three days after the final injection, followed by SERM therapy once HCG use concludes.